S2DV: converting SMILES to a drug vector for predicting the activity of anti-HBV small molecules.
Brief Bioinform. 2022 Mar 10;23(2):bbab593. doi: 10.1093/bib/bbab593.
Brief Bioinform. 2022.
PMID: 35062019
Free PMC article.